Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cencora Inc (COR)

Cencora Inc (COR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

How Is Cardinal Health’s Stock Performance Compared to Other Health Care Service Stocks?

Based in Dublin, Ohio, Cardinal Health, Inc. (CAH) stands as a major global player in healthcare solutions, offering a wide range of services spanning pharmaceutical distribution, medical and lab products, and data-driven innovations. With a market capitalization of $31.9 billion, the company operates across more than 30 countries and supports a workforce of nearly 49,000.

Companies worth $10 billion or more are generally described as "large-cap stocks," Cardinal Health fits this bill perfectly. Cardinal Health plays a vital role in strengthening healthcare supply chains and delivering value to hospitals, pharmacies, and providers worldwide.

Cardinal recently touched its 52-week high of $162.94 on June 13....

Fundamentals

See More
  • Market Capitalization, $K 56,693,220
  • Shares Outstanding, K 193,823
  • Annual Sales, $ 293,959 M
  • Annual Income, $ 1,509 M
  • EBIT $ 4,048 M
  • EBITDA $ 5,166 M
  • 60-Month Beta 0.58
  • Price/Sales 0.19
  • Price/Cash Flow 14.87
  • Price/Book 48.54

Options Overview Details

View History
  • Implied Volatility 23.75% ( +2.80%)
  • Historical Volatility 29.12%
  • IV Percentile 74%
  • IV Rank 38.99%
  • IV High 36.68% on 04/08/25
  • IV Low 15.48% on 11/08/24
  • Put/Call Vol Ratio 0.33
  • Today's Volume 539
  • Volume Avg (30-Day) 673
  • Put/Call OI Ratio 0.87
  • Today's Open Interest 47,043
  • Open Int (30-Day) 44,771

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 3.79
  • Number of Estimates 7
  • High Estimate 3.90
  • Low Estimate 3.65
  • Prior Year 3.34
  • Growth Rate Est. (year over year) +13.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
281.57 +4.13%
on 06/10/25
296.95 -1.26%
on 05/20/25
+2.98 (+1.03%)
since 05/16/25
3-Month
260.23 +12.67%
on 03/18/25
309.35 -5.22%
on 05/07/25
+32.24 (+12.35%)
since 03/17/25
52-Week
218.65 +34.10%
on 10/07/24
309.35 -5.22%
on 05/07/25
+58.50 (+24.93%)
since 06/17/24

Most Recent Stories

More News
How Is Cardinal Health’s Stock Performance Compared to Other Health Care Service Stocks?

Cardinal Health has outperformed its healthcare service peers over the past year, with analysts maintaining a positive outlook on its continued growth trajectory.

XHS : 96.33 (-0.77%)
COR : 293.20 (+0.24%)
CAH : 164.91 (+1.54%)
Is Cencora Stock Outperforming the Dow?

Due to Cencora’s strong performance relative to the broader Dow over the past year, Wall Street analysts remain bullish about the stock’s prospects.

COR : 293.20 (+0.24%)
$DOWI : 42,215.80 (-0.70%)
CAH : 164.91 (+1.54%)
McKesson Stock: Is MCK Outperforming the Healthcare Sector?

McKesson has significantly outpaced the broader healthcare sector over the past year, and analysts remain strongly bullish on the stock’s prospects.

XLV : 133.47 (-1.65%)
MCK : 724.38 (+0.67%)
COR : 293.20 (+0.24%)
MCK Stock Gains More Than 4% Following Strong Q4: Should You Buy Now?

McKesson’s MCK shares have gained 4.4% following its fourth-quarter fiscal 2025 earnings release on May 9. The post-earnings upside reflects growing investor confidence in McKesson’s strategic execution...

MCK : 724.38 (+0.67%)
COR : 293.20 (+0.24%)
CAH : 164.91 (+1.54%)
Do Wall Street Analysts Like Cencora Stock?

Cencora has significantly outperformed the broader market over the past year, and analysts remain strongly bullish on the stock’s prospects.

$SPX : 5,982.72 (-0.84%)
COR : 293.20 (+0.24%)
PPH : 88.19 (-2.07%)
Stocks Finish Higher as Chip Stocks Rally

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +0.43%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. June E-mini S&P...

GOOGL : 175.95 (-0.46%)
ANET : 89.68 (-5.69%)
AVGO : 249.37 (-1.08%)
SRPT : 21.56 (+2.96%)
ADI : 227.44 (-1.88%)
TXN : 197.69 (-0.77%)
$IUXX : 21,719.08 (-1.00%)
ASML : 759.86 (-1.98%)
ZNU25 : 110-245 (-0.07%)
ESU25 : 6,056.25 (+0.29%)
QCOM : 154.46 (-1.54%)
GFS : 36.60 (-2.66%)
Stocks Turn Mixed Ahead of FOMC Meeting Results

The S&P 500 Index ($SPX ) (SPY ) today is up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.30%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.23%. June E-mini S&P futures (ESM25...

ANET : 89.68 (-5.69%)
CRWD : 492.03 (+2.64%)
SRPT : 21.56 (+2.96%)
$SPX : 5,982.72 (-0.84%)
SMCI : 43.11 (-1.33%)
COR : 293.20 (+0.24%)
$IUXX : 21,719.08 (-1.00%)
NQU25 : 22,027.75 (+0.33%)
ROK : 320.41 (-1.20%)
DIS : 118.13 (-1.13%)
QQQ : 529.08 (-0.98%)
ZNU25 : 110-245 (-0.07%)
Cencora: Fiscal Q2 Earnings Snapshot

Cencora: Fiscal Q2 Earnings Snapshot

COR : 293.20 (+0.24%)
Earnings Preview: What To Expect From Cencora's Report

Cencora is scheduled to report its second-quarter results next month, with analysts projecting a single-digit earnings growth.

XLV : 133.47 (-1.65%)
$SPX : 5,982.72 (-0.84%)
COR : 293.20 (+0.24%)
Segmental Performance to Drive RVTY's Q1 Earnings: Is a Beat Likely?

Revvity, Inc. RVTY is slated to report first-quarter 2025 results on April 28, before market open.In the last reported quarter, the company delivered an earnings surprise of 4.41%. RVTY’s earnings beat...

GMED : 58.14 (-1.22%)
COR : 293.20 (+0.24%)
CAH : 164.91 (+1.54%)
RVTY : 94.16 (-2.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.

See More

Key Turning Points

3rd Resistance Point 298.00
2nd Resistance Point 296.66
1st Resistance Point 294.93
Last Price 293.20
1st Support Level 291.86
2nd Support Level 290.52
3rd Support Level 288.79

See More

52-Week High 309.35
Last Price 293.20
Fibonacci 61.8% 274.70
Fibonacci 50% 264.00
Fibonacci 38.2% 253.30
52-Week Low 218.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar